Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
SURMOUNT-1 (tirzepatide) data SURMOUNT-1 (N=2,539) tested tirzepatide 5, 10, and 15 mg against placebo over 72 weeks, reporting 15.0%, 19.5%, and 20.9% mean weight loss at the three doses respectively [2]
Share to X
More Info SKU : 137603 Customer Reviews 4.7 / 5 Based on 57 reviews 5 46 4 7 3 1 2 1 1 2 Where do I review this product
InBodys fat-free mass data enables precise protein prescriptions
For patients who prefer in-person care, walk-in and same-day medical weight loss consultations are available at the Hollywood clinic location, conveniently located near Aventura
Retatrutide is a newer triple-agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously, supporting appetite control, calorie expenditure, and broader metabolic optimization
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
